Researchers were unsure whether alpha particles would aid or hinder fusion. Simulations suggest they help, by dampening turbulence.
In the biggest venture capital financing this week, clinical-stage radiopharmaceutical AdvanCell has closed a $315 million ...
Tunnelling out Illustration of the alpha decay of tellurium-104 over the RIBF at RIKEN. (Courtesy: Robert Grzywacz/University of Tennessee) Physicists headed up by a team at the University of ...
Researchers from San Jose State University and Sandia National Laboratories published a technical paper titled “Self-Heating and Radiation Hardness Studies of 3nm GAA-FET-Based SRAM with Different ...
A PRL study has linked Chandrayaan-3's Shiv Shakti soil readings with the lunar meteorite ALHA 81005. The match offers fresh ...
Marvel Rivals visual clutter fix arrives July 16, 2026 as NetEase’s Combat Clarity Upgrade reduces particle effects across 19 ...
Novartis already received FDA approval of ITVISMA as a gene therapy for the treatment of patients with SMA. Read why NVS stock is downgraded to a hold.
Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX), backed by significant analyst-implied upside, ranks among the overlooked ...
A groundbreaking scientific report released today by the Deep Sea Mining Campaign exposes a critical, unaddressed threat to global ocean health: the mobilisation of naturally occurring radioactive ...
Free interactive tool uses particle physics-inspired Burkeanomics to predict prosperity impacts from policies in the ...
Eventually, we'll launch a mission dedicated solely to studying an interstellar object. When that day comes, which one should ...
Researchers in Japan are developing world-leading expertise in making and using the alpha particle emitter, astatine-211 (211 At), which has potential for use as a strong radionuclide therapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results